are you suggesting GOAT has PCHM in the portfolio or I'm a Goat ?
GOAT holds a small portfolio of global stocks determined by Morningstar’s research team to have “wide moats”—sustainable competitive advantages such as high customer switching cost, internal cost advantages, intellectual property, network effects, and efficiencies of scale. The portfolio is further screened to remove the bottom 20% of eligible firms by 12-month momentum. Finally, Morningstar uses a proprietary valuation model to select only those companies thought to be trading at attractive prices. GOAT is equal-weighted with a staggered semi-annual rebalance: half the portfolio is reconstituted and rebalanced quarterly. Sibling fund MOAT provides US-only exposure with the same methodology.